Evans, Christopher P.
Tel Aviv University · University of California, Davis
7 papers on CoChatORCID 0000-0001-5626-8901
Most cited papers
- Verified
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
Beer, T. M., Armstrong, A. J., Rathkopf, D. E., Loriot, Y., Sternberg, C. N., Higano, C. S., Iversen, P., Bhattacharya, S., Carles, J., Chowdhury, S., et al. (2014) · New England Journal of Medicine
Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment
Cited by 3,028
- Verified
Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study
Aggarwal, R., Huang, J., Alumkal, J. J., Zhang, L., Feng, F. Y., Thomas, G. V., Weinstein, A. S., Friedl, V., Zhang, C., Witte, O. N., et al. (2018) · Journal of Clinical Oncology
Prostate Cancer Treatment and ResearchNeuroblastoma Research and Treatments
Cited by 810
- Verified
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
Quigley, D. A., Dang, H. X., Zhao, S. G., Lloyd, P., Aggarwal, R., Alumkal, J. J., Foye, A., Kothari, V., Perry, M. D., Bailey, A. M., et al. (2018) · Cell
Prostate Cancer Treatment and ResearchCancer Genomics and Diagnostics
Cited by 733
- Verified
Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model
Nguyen, H. G., Yang, J. C., Kung, H.-J., Shi, X.-B., Tilki, D., Lara, P. N., DeVere White, R. W., Gao, A. C., & Evans, C. P. (2014) · Oncogene
Autophagy in Disease and TherapyProstate Cancer Treatment and Research
Cited by 212
- Verified
Management of patients with advanced prostate cancer: report from the Advanced Prostate Cancer Consensus Conference 2021
Gillessen, S., Armstrong, A., Attard, G., Beer, T. M., Beltran, H., Bjartell, A., Bossi, A., Briganti, A., Bristow, R. G., Bulbul, M., et al. (2022) · European Urology
Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment
Cited by 130
- Verified
Aberrant activation of the androgen receptor by NF-κB2/p52 in prostate cancer cells.
Nadiminty, N., Lou, W., Sun, M., Chen, J., Yue, J., Kung, H.-J., Evans, C. P., Zhou, Q., & Gao, A. C. (2010) · Cancer Research
Prostate Cancer Treatment and ResearchNF-κB Signaling Pathways
Cited by 113
- Verified
Aberrant activation of androgen receptor in a new neuropeptide- autocrine model of androgen-insensitive prostate cancer.
Yang, J. C., Ok, J.-H., Busby, J. E., Borowsky, A. D., Kung, H.-J., & Evans, C. P. (2009) · Cancer Research
Prostate Cancer Treatment and ResearchCancer, Lipids, and Metabolism
Cited by 70
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free